|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.58 EUR | +3.73% |
|
+1.19% | +20.37% |
| 11:24am | BASF SE : Goldman Sachs reaffirms its Buy rating | ZD |
| 10:51am | BASF Unit Opens Fermentation Plant for Crop Protection Products in Germany | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 78.6B | 87.33B | 68.9B | 65.26B | 59.66B | |||||
Total Revenues | 78.6B | 87.33B | 68.9B | 65.26B | 59.66B | |||||
Cost of Goods Sold, Total | 59.09B | 66.7B | 52.51B | 48.51B | 45.53B | |||||
Gross Profit | 19.51B | 20.63B | 16.4B | 16.75B | 14.13B | |||||
Selling General & Admin Expenses, Total | 9.9B | 11.2B | 10.38B | 10.35B | 8.88B | |||||
Exploration / Drilling Costs, Total | - | - | - | - | - | |||||
Stock-Based Compensation (IS) | 37M | - | - | - | - | |||||
R&D Expenses | 2.22B | 2.3B | 2.13B | 2.06B | 2B | |||||
Other Operating Expenses | -115M | 275M | 1.02B | 1.48B | 779M | |||||
Other Operating Expenses, Total | 12.04B | 13.77B | 13.53B | 13.89B | 11.66B | |||||
Operating Income | 7.47B | 6.86B | 2.87B | 2.86B | 2.47B | |||||
Interest Expense, Total | -506M | -631M | -868M | -936M | -924M | |||||
Interest And Investment Income | 257M | 354M | 453M | 521M | 406M | |||||
Net Interest Expenses | -249M | -277M | -415M | -415M | -518M | |||||
Income (Loss) On Equity Invest. | 960M | -4.5B | 78M | 653M | 1.06B | |||||
Currency Exchange Gains (Loss) | -109M | -152M | -327M | -161M | -188M | |||||
Other Non Operating Income (Expenses) | -72M | -20M | -93M | 17M | 92M | |||||
EBT, Excl. Unusual Items | 8B | 1.91B | 2.11B | 2.96B | 2.91B | |||||
Restructuring Charges | -433M | -486M | -628M | -806M | -1.11B | |||||
Merger & Related Restructuring Charges | -28M | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | -114M | -107M | -112M | -118M | -33M | |||||
Gain (Loss) On Sale Of Assets | 129M | 250M | 43M | 35M | 668M | |||||
Asset Writedown | -103M | -375M | 6M | - | 8M | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 7.45B | 1.19B | 1.42B | 2.07B | 2.45B | |||||
Income Tax Expense | 1.43B | 1.58B | 1.04B | 616M | 907M | |||||
Earnings From Continuing Operations | 6.02B | -391M | 379M | 1.45B | 1.54B | |||||
Earnings Of Discontinued Operations | -36M | - | - | - | 185M | |||||
Net Income to Company | 5.98B | -391M | 379M | 1.45B | 1.73B | |||||
Minority Interest | -459M | -236M | -154M | -155M | -107M | |||||
Net Income - (IS) | 5.52B | -627M | 225M | 1.3B | 1.62B | |||||
Net Income to Common Incl Extra Items | 5.52B | -627M | 225M | 1.3B | 1.62B | |||||
Net Income to Common Excl. Extra Items | 5.56B | -627M | 225M | 1.3B | 1.43B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.01 | -0.7 | 0.25 | 1.45 | 1.82 | |||||
Basic EPS - Continuing Operations | 6.05 | -0.7 | 0.25 | 1.45 | 1.61 | |||||
Basic Weighted Average Shares Outstanding | 918M | 902M | 893M | 893M | 892M | |||||
Net EPS - Diluted | 6 | -0.7 | 0.25 | 1.45 | 1.81 | |||||
Diluted EPS - Continuing Operations | 6.04 | -0.7 | 0.25 | 1.45 | 1.6 | |||||
Diluted Weighted Average Shares Outstanding | 920M | 902M | 895M | 895M | 894M | |||||
Normalized Basic EPS | 4.94 | 1.06 | 1.31 | 1.9 | 1.92 | |||||
Normalized Diluted EPS | 4.93 | 1.06 | 1.3 | 1.89 | 1.92 | |||||
Dividend Per Share | 3.4 | 3.4 | 3.4 | 2.25 | 2.25 | |||||
Payout Ratio | 54.88 | -489.95 | 1.35K | 233.82 | 128.84 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 11.01B | 10.23B | 6.21B | 6.24B | 6.05B | |||||
EBITA | 7.47B | 7.48B | 3.45B | 3.39B | 2.47B | |||||
EBIT | 7.47B | 6.86B | 2.87B | 2.86B | 2.47B | |||||
EBITDAR | 11.2B | 10.42B | 6.41B | 6.44B | 6.23B | |||||
Effective Tax Rate - (Ratio) | 19.2 | 132.86 | 73.31 | 29.77 | 37.05 | |||||
Total Current Taxes | 1.44B | 1.28B | 1.1B | 1.01B | 1.2B | |||||
Total Deferred Taxes | -6M | 301M | -61M | -398M | -295M | |||||
Normalized Net Income | 4.54B | 956M | 1.17B | 1.69B | 1.71B | |||||
Interest Capitalized | 29M | 40M | 80M | 147M | 152M | |||||
Interest on Long-Term Debt | 36M | 40M | 53M | 66M | 61M | |||||
Non-Cash Pension Expense | 505M | 438M | 316M | 341M | 225M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 8.41B | 9.61B | 8.79B | 8.78B | 7.51B | |||||
General and Administrative Expenses | 1.41B | 1.52B | 1.51B | 1.47B | 1.34B | |||||
Research And Development Expense From Footnotes | 2.22B | 2.3B | 2.13B | 2.06B | 2B | |||||
Exploration/Drilling Costs | - | - | - | - | - | |||||
Net Rental Expense, Total | 186M | 191M | 197M | 197M | 180M | |||||
Imputed Operating Lease Interest Expense | 39.48M | 51.15M | 70.65M | 75.29M | 65.65M | |||||
Imputed Operating Lease Depreciation | 147M | 140M | 126M | 122M | 114M | |||||
Stock-Based Comp., Other (Total) | 64M | 20M | 26M | 24M | 20M | |||||
Total Stock-Based Compensation | 64M | 20M | 26M | 24M | 20M |
- Stock Market
- Equities
- BAS Stock
- Financials BASF SE
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















